12 Month Price Forecast For BSX
Distance to BSX Price Forecasts
BSX Price Momentum
🤔 Considering Boston Scientific (BSX)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 11, 2025 4:45 AM UTC
BSX Analyst Ratings & Price Targets
Based on our analysis of 31 Wall Street analysts, BSX has a bullish consensus with a median price target of $118.00 (ranging from $84.00 to $135.00). The overall analyst rating is Strong Buy (9.1/10). Currently trading at $106.18, the median forecast implies a 11.1% upside. This outlook is supported by 30 Buy, 3 Hold, and 1 Sell ratings.
Conversely, the most conservative target is provided by Marie Thibault at BTIG, suggesting a 20.9% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
BSX Analyst Consensus
BSX Price Target Range
Latest BSX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for BSX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 10, 2025 | Stifel | Rick Wise | Buy | Maintains | $120.00 |
| Feb 10, 2025 | Barclays | Matt Miksic | Overweight | Maintains | $118.00 |
| Feb 7, 2025 | UBS | Danielle Antalffy | Buy | Maintains | $130.00 |
| Feb 6, 2025 | Morgan Stanley | Patrick Wood | Overweight | Maintains | $120.00 |
| Feb 6, 2025 | Raymond James | Jayson Bedford | Strong Buy | Maintains | $122.00 |
| Feb 6, 2025 | RBC Capital | Shagun Singh | Outperform | Maintains | $116.00 |
| Feb 6, 2025 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Feb 6, 2025 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $118.00 |
| Feb 6, 2025 | Stifel | Rick Wise | Buy | Maintains | $115.00 |
| Feb 6, 2025 | Citigroup | Joanne Wuensch | Buy | Maintains | $122.00 |
| Feb 3, 2025 | Piper Sandler | Matt O'Brien | Overweight | Maintains | $115.00 |
| Jan 31, 2025 | Raymond James | Jayson Bedford | Strong Buy | Maintains | $119.00 |
| Dec 18, 2024 | Truist Securities | Richard Newitter | Buy | Maintains | $110.00 |
| Dec 16, 2024 | JP Morgan | Robbie Marcus | Overweight | Maintains | $110.00 |
| Dec 12, 2024 | TD Cowen | Joshua Jennings | Buy | Maintains | $110.00 |
| Dec 11, 2024 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $100.00 |
| Dec 11, 2024 | Citigroup | Joanne Wuensch | Buy | Maintains | $107.00 |
| Dec 9, 2024 | Canaccord Genuity | William Plovanic | Buy | Maintains | $101.00 |
| Nov 27, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Nov 18, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
Stocks Similar to Boston Scientific Corp
The following stocks are similar to Boston Scientific based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Boston Scientific Corp (BSX) Financial Data
Boston Scientific Corp has a market capitalization of $156.30B with a P/E ratio of 84.8x. The company generates $15.91B in trailing twelve-month revenue with a 11.3% profit margin.
Revenue growth is +19.3% quarter-over-quarter, while maintaining an operating margin of +17.1% and return on equity of +8.9%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Boston Scientific Corp (BSX) Company Overview
About Boston Scientific Corp
Develops and markets medical devices worldwide.
Boston Scientific Corporation generates revenue by creating a diverse range of medical devices across various interventional specialties, including MedSurg and Cardiovascular segments. They provide innovative solutions for diagnosing and treating conditions in areas such as gastrointestinal, urological, neurological, and cardiovascular health, allowing healthcare providers to improve patient outcomes.
Founded in 1979 and headquartered in Marlborough, Massachusetts, the company has a strong focus on advancing medical technology through research and development. Their comprehensive product offerings include devices for chronic pain management, heart monitoring, and cancer treatment, positioning them as a key player in the global medical device market.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
48,000
CEO
Mr. Michael F. Mahoney
Country
United States
IPO Year
1992
Website
www.bostonscientific.comBoston Scientific Corp (BSX) Latest News & Analysis
New Strong Buy Stocks for February 10th
1 day agoPFIS, BSX, ENVA, NFG, and NLY were added to the Zacks Rank #1 (Strong Buy) List on February 10, 2025.
The addition of PFIS, BSX, ENVA, NFG, and NLY to the Zacks Rank #1 (Strong Buy) List signals strong growth potential and favorable investment sentiment, indicating likely stock price appreciation.
Five stocks showing strong momentum for February include APH, BSX, NLY, PNFP, and FHN.
Strong momentum in these five stocks indicates potential for price appreciation, attracting investors looking for growth opportunities in February.
Best Momentum Stocks to Buy for February 10th
22 hours agoBSX, ENVA, and CFR are ranked as Zacks Rank #1 (Strong Buy) momentum stocks as of February 10, 2025.
BSX, ENVA, and CFR being ranked as Strong Buy indicates strong potential for price appreciation, signaling positive momentum and investment opportunities for those stocks.
Boston Scientific projects annual profit exceeding Wall Street estimates, driven by consistent demand for its heart devices.
Boston Scientific's strong profit forecast signals robust demand in the healthcare sector, potentially boosting stock performance and investor confidence in the company.
Boston Scientific will hold its Q4 2024 Earnings Conference Call on February 5, 2025, at 8:00 AM ET, featuring key executives and analysts from major financial institutions.
The Boston Scientific Q4 2024 earnings call highlights key insights on company performance, guiding investor decisions on stock valuation and future growth potential.
Boston Scientific Corporation (NYSE: BSX) reported Q4 2024 net sales of $4.561 billion, up 22.4% reported, 23.1% operational, and 19.5% organic year-over-year.
Boston Scientific's strong Q4 2024 sales growth indicates robust demand and operational efficiency, potentially boosting investor confidence and stock performance.
Frequently Asked Questions About BSX Stock
What is Boston Scientific Corp's (BSX) stock forecast for 2025?
Based on our analysis of 31 Wall Street analysts, Boston Scientific Corp (BSX) has a median price target of $118.00. The highest price target is $135.00 and the lowest is $84.00.
Is BSX stock a good investment in 2025?
According to current analyst ratings, BSX has 30 Buy ratings, 3 Hold ratings, and 1 Sell ratings. The stock is currently trading at $106.18. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for BSX stock?
Wall Street analysts predict BSX stock could reach $118.00 in the next 12 months. This represents a 11.1% increase from the current price of $106.18. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Boston Scientific Corp's business model?
Boston Scientific Corporation generates revenue by creating a diverse range of medical devices across various interventional specialties, including MedSurg and Cardiovascular segments. They provide innovative solutions for diagnosing and treating conditions in areas such as gastrointestinal, urological, neurological, and cardiovascular health, allowing healthcare providers to improve patient outcomes.
What is the highest forecasted price for BSX Boston Scientific Corp?
The highest price target for BSX is $135.00 from at , which represents a 27.1% increase from the current price of $106.18.
What is the lowest forecasted price for BSX Boston Scientific Corp?
The lowest price target for BSX is $84.00 from Marie Thibault at BTIG, which represents a -20.9% decrease from the current price of $106.18.
What is the overall BSX consensus from analysts for Boston Scientific Corp?
The overall analyst consensus for BSX is bullish. Out of 31 Wall Street analysts, 30 rate it as Buy, 3 as Hold, and 1 as Sell, with a median price target of $118.00.
How accurate are BSX stock price projections?
Stock price projections, including those for Boston Scientific Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
